JP2021535147A5 - - Google Patents

Info

Publication number
JP2021535147A5
JP2021535147A5 JP2021510761A JP2021510761A JP2021535147A5 JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5 JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
composition
acceptable salt
teeth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535147A (ja
JP7437384B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049195 external-priority patent/WO2020047496A1/en
Publication of JP2021535147A publication Critical patent/JP2021535147A/ja
Publication of JP2021535147A5 publication Critical patent/JP2021535147A5/ja
Application granted granted Critical
Publication of JP7437384B2 publication Critical patent/JP7437384B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510761A 2018-08-31 2019-08-30 イソキノリンステロイド抱合体およびその使用 Active JP7437384B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862725941P 2018-08-31 2018-08-31
US62/725,941 2018-08-31
PCT/US2019/049195 WO2020047496A1 (en) 2018-08-31 2019-08-30 Isoquinoline-steroid conjugates and uses thereof

Publications (3)

Publication Number Publication Date
JP2021535147A JP2021535147A (ja) 2021-12-16
JP2021535147A5 true JP2021535147A5 (enExample) 2022-08-31
JP7437384B2 JP7437384B2 (ja) 2024-02-22

Family

ID=69639319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510761A Active JP7437384B2 (ja) 2018-08-31 2019-08-30 イソキノリンステロイド抱合体およびその使用

Country Status (10)

Country Link
US (2) US11059789B2 (enExample)
EP (1) EP3843736A4 (enExample)
JP (1) JP7437384B2 (enExample)
KR (1) KR20210053301A (enExample)
CN (1) CN112638386A (enExample)
AU (2) AU2019328590B2 (enExample)
BR (1) BR112021003613A2 (enExample)
MX (1) MX2021002380A (enExample)
SG (1) SG11202101517PA (enExample)
WO (1) WO2020047496A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7437384B2 (ja) 2018-08-31 2024-02-22 アエリエ ファーマシューティカルズ インコーポレイテッド イソキノリンステロイド抱合体およびその使用
US20220347305A1 (en) 2019-08-07 2022-11-03 Ripple Therapeutics Corporation Controlled release drug dimers
WO2021207486A1 (en) * 2020-04-08 2021-10-14 Aerie Pharmaceuticals, Inc. Treatments
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
CN117561270A (zh) * 2021-04-29 2024-02-13 爱瑞制药公司 稳定的异喹啉-皮质类固醇缀合物及其用途
US20250057962A1 (en) * 2021-11-03 2025-02-20 Ripple Therapeutics Corporation Processable compositions and use for the same
CN115340472B (zh) * 2022-09-19 2024-05-07 合肥工业大学 一种谷氨酸衍生物及其合成方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3193459A (en) 1955-07-01 1965-07-06 Upjohn Co Steroid hemisuccinate compositions and method for extemporaneous administration
ES2580108T3 (es) * 2005-07-11 2016-08-19 Aerie Pharmaceuticals, Inc Compuestos de isoquinolina
US8455513B2 (en) * 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US20100041633A1 (en) * 2007-02-05 2010-02-18 Nicox S.A. Nitric oxide releasing steroids
US8450344B2 (en) * 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (en) * 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
US9402912B2 (en) * 2013-03-08 2016-08-02 Allergan, Inc. Antibiotic conjugates directly linked with steroid drugs
CN105025929A (zh) 2013-03-08 2015-11-04 阿勒根公司 环孢菌素a-类固醇缀合物
US20140275160A1 (en) * 2013-03-15 2014-09-18 Aerie Pharmaceuticals, Inc. Combination therapy
BR112019003232A2 (pt) * 2016-08-19 2019-06-18 Aerie Pharmaceuticals Inc compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção
JP7437384B2 (ja) 2018-08-31 2024-02-22 アエリエ ファーマシューティカルズ インコーポレイテッド イソキノリンステロイド抱合体およびその使用

Similar Documents

Publication Publication Date Title
US11026900B2 (en) Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
CN114008035A (zh) 一种shp2磷酸酶变构抑制剂
JP2024133475A5 (enExample)
JP2017527532A5 (enExample)
JP2014526503A5 (enExample)
JP2018109022A5 (enExample)
JP2020075939A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
RU2014111069A (ru) Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение
JP2017510610A5 (enExample)
JP2022506062A5 (enExample)
JP2021530453A5 (enExample)
JP2020534270A5 (enExample)
JP2019508476A5 (enExample)
JPWO2020175629A5 (enExample)
RU2018109902A (ru) Виды комбинированной терапии для лечения рака
CR20210043A (es) Forma de dosificación farmacèutica administrable por vía oral con liberación modificada
JPWO2021187548A5 (enExample)
JP2023553253A5 (enExample)
JP2014148552A5 (enExample)
JP2024543345A5 (enExample)
JP2018529747A5 (enExample)
JP2013507382A5 (enExample)
JP2021511352A5 (enExample)
JP2016539148A5 (enExample)